Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial

Lack of effective targeted therapy in metastatic esophageal squamous cell carcinoma (ESCC) underscores the urgent need for identifying new treatment approaches for this challenging disease. We sought to assess the addition of cetuximab to paclitaxel-cisplatin chemotherapy for first-line treatment in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zhihao Lu, Yanqiao Zhang, Qingxia Fan, Yueyin Pan, Da Jiang, Ping Lu, Jingdong Zhang, Xianglin Yuan, Jifeng Feng, Shujun Yang, Wenbin Yue, Lin Zhao, Yunhua Xu, Jinhua Luo, Lin Shen
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2022-05-01
Col·lecció:	The Innovation
Matèries:	esophageal squamous cell carcinoma cetuximab EGFR chemotherapy
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666675822000352
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!